Author name: TB Alliance

The TB Alliance visited Russia and Ukraine in September as part of its ongoing assessment of R&D capacity in high-burden

PA-824, the first TB Alliance compound, acquired through an exclusive license deal with Chiron Corporation in June 2002, has moved

The TB Alliance held its annual Stakeholder Association meeting in Paris on October 30. The event, hosted by La Maison

Dr. Valerie Mizrahi knows what it’s like to bridge two worlds. A Zimbabwean native, she trained in South Africa, but

The TB Alliance has assembled a portfolio of promising anti-TB compounds and is overseeing their development. The compounds, which were

In this article, we discuss the challenges, recent developments and new thinking on drug R&D for neglected diseases through public–private

The Working Group on TB Drug Development (WG) held its annual meeting in Paris on October 30, 2003 at La

Global strategies for fighting tuberculosis, malaria and AIDS are just now coming together. Especially this year, we’ve seen a marked

The HIV/AIDS epidemic has proven the most effective way of spreading tuberculosis, or TB, especially in sub-Saharan Africa. The World

Annual Meeting Agenda La Maison de L’Amerique Latine Paris, France 30 October 2003 Working Agenda 8.30 Opening 9.15 Scientific UpdateChaired